- Report
- January 2025
- 80 Pages
India
From €3131EUR$3,500USD£2,683GBP
- Report
- October 2024
- 136 Pages
North America
From €3578EUR$4,000USD£3,066GBP
- Report
- September 2024
- 82 Pages
Japan
From €3131EUR$3,500USD£2,683GBP
- Report
- August 2024
- 80 Pages
Japan
From €3131EUR$3,500USD£2,683GBP
- Report
- October 2023
- 84 Pages
Canada
From €3131EUR$3,500USD£2,683GBP
- Report
- October 2023
- 89 Pages
Egypt
From €3131EUR$3,500USD£2,683GBP
- Report
- August 2023
- 75 Pages
Israel
From €3131EUR$3,500USD£2,683GBP
- Report
- August 2023
- 74 Pages
Canada
From €3131EUR$3,500USD£2,683GBP
- Report
- August 2023
- 73 Pages
Israel
From €3131EUR$3,500USD£2,683GBP
- Report
- October 2024
- 200 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Report
- January 2024
- 200 Pages
Global
From €3712EUR$4,150USD£3,181GBP
- Report
- August 2026
- 30 Pages
From €2460EUR$2,750USD£2,108GBP
- Report
- July 2026
- 200 Pages
From €7148EUR$7,990USD£6,124GBP
- Report
- July 2026
- 135 Pages
From €7148EUR$7,990USD£6,124GBP
- Report
- July 2026
- 200 Pages
From €7148EUR$7,990USD£6,124GBP
- Report
- June 2025
- 150 Pages
Global
From €3355EUR$3,750USD£2,874GBP
- Drug Pipelines
- April 2025
- 40 Pages
Global
From €1118EUR$1,250USD£958GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1118EUR$1,250USD£958GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1342EUR$1,500USD£1,150GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1342EUR$1,500USD£1,150GBP

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events.
The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more